3-((2-Chloropyridin-4-yl)oxy)-6-iodo-2-methylpyridine, 98%, 5g

1-(4-Bromophenyl)cyclopentanecarbonitrile, 95.0%, 5g

Maleic acid, min. 99%, Ph.Eur., BP, 500 g, plastic packaging.

4-(1-Hydroxyethyl)phenol, 95.0%, 250mg

2,6-Dichloro-5-nitroquinoline, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyloct-7-enoic acid, 95.0%, 1g

2-Butyl-1H-imidazole-5-carboxaldehyde>98.0%(GC)5g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid, 97%, 250mg

1,2,3,4-Tetrahydroisoquinoline-8-carboxylic acid, 95.0%, 1g

Methyl 1-oxoisoindoline-5-carboxylate, 95.0%, 1g

Ethyl 2-bromoimidazo[2,1-b][1,3,4]thiadiazole-6-carboxylate, 97%, 2g

BIFONAZOLE, 95%, 100g

3-IODO-5-METHYLCINNAMONITRILE, 95.0%, 250mg